The Development of INT131 as a Selective PPAR<svg style="vertical-align:-2.53308pt;width:8.6125002px;" id="M1" height="10.5" version="1.1" viewBox="0 0 8.6125002 10.5" width="8.6125002"  xmlns="http://www.w3.org/2000/svg">
	<g transform="matrix(1.25,0,0,-1.25,0,10.5)">
		<g transform="translate(72,-63.6)">
			<text transform="matrix(1,0,0,-1,-71.95,66.17)">
				<tspan style="font-size: 12.50px; " x="0" y="0">𝜸</tspan>
			</text>

		</g>
	</g>
</svg> Modulator: Approach to a Safer Insulin Sensitizer

<table><i>Carcinogenicity
risk in relation to spectrum of PPAR activation.</i> Propensity for demonstrating
carcinogenic activity is predicted to increase with broader PPAR activating
activity.</table>

PPAR Research

fig10

Figure 10

Figure 10: The Development of INT131 as a Selective PPAR<svg style="vertical-align:-2.53308pt;width:8.6125002px;" id="M1" height="10.5" version="1.1" viewBox="0 0 8.6125002 10.5" width="8.6125002"  xmlns="http://www.w3.org/2000/svg">
	<g transform="matrix(1.25,0,0,-1.25,0,10.5)">
		<g transform="translate(72,-63.6)">
			<text transform="matrix(1,0,0,-1,-71.95,66.17)">
				<tspan style="font-size: 12.50px; " x="0" y="0">𝜸</tspan>
			</text>

		</g>
	</g>
</svg> Modulator: Approach to a Safer Insulin Sensitizer 

PPAR Research

The Development of INT131 as a Selective PPAR 𝜸 Modulator: Approach to a Safer Insulin Sensitizer

Figure 10

The Development of INT131 as a Selective PPAR Modulator: Approach to a Safer Insulin Sensitizer